Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use STRENSIQ safely and effectively. See full prescribing information for STRENSIQ. STRENSIQ® (asfotase alfa) injection, for subcutaneous use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
STRENSIQ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
- generic_name
- asfotase alfa
- product_names
- ASFOTASE ALFA
- ndc
- 25682-010, 25682-010-01, 25682-010-12, 25682-013, 25682-013-01, 25682-013-12, 25682-016, 25682-016-01, 25682-016-12, 25682-019, 25682-019-01, 25682-019-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en